Women face systemic delays in heart disease diagnosis and care

A global patient-led study reveals that women frequently postpone seeking medical attention for heart symptoms, often prioritizing family obligations over their own health. Presented at the ACNAP Congress 2026, the research underscores how clinician bias and the misattribution of cardiac signs to anxiety contribute to life-threatening diagnostic delays.

The IPEC2 study, conducted by the Global Heart Hub across eight countries, highlights a critical disconnect between the prevalence of cardiovascular disease—the leading cause of death among women—and the speed at which patients receive care. Data gathered from women with conditions ranging from heart valve disease to elevated LDL cholesterol show that many patients are not diagnosed until they reach the point of a major cardiac event.

Professor Vijay Kunadian of Newcastle University noted that while modern medicine offers effective treatments for high cholesterol, these therapies remain inaccessible to women who fall through the gaps of the current healthcare pathway. Beyond individual hesitation, the study identifies a pervasive gender bias where clinicians dismiss symptoms as non-cardiac or suggest patients are simply "too young" for heart disease. These findings emphasize the urgent need for a shift toward 'heart first' clinical approaches that recognize the diverse ways cardiovascular issues manifest in women, moving beyond the traditional male-centric diagnostic guidelines.